Literature DB >> 29743276

Non-coding RNA in cystic fibrosis.

Arlene M A Glasgow1, Chiara De Santi1, Catherine M Greene2.   

Abstract

Non-coding RNAs (ncRNAs) are an abundant class of RNAs that include small ncRNAs, long non-coding RNAs (lncRNA) and pseudogenes. The human ncRNA atlas includes thousands of these specialised RNA molecules that are further subcategorised based on their size or function. Two of the more well-known and widely studied ncRNA species are microRNAs (miRNAs) and lncRNAs. These are regulatory RNAs and their altered expression has been implicated in the pathogenesis of a variety of human diseases. Failure to express a functional cystic fibrosis (CF) transmembrane receptor (CFTR) chloride ion channel in epithelial cells underpins CF. Secondary to the CFTR defect, it is known that other pathways can be altered and these may contribute to the pathophysiology of CF lung disease in particular. For example, quantitative alterations in expression of some ncRNAs are associated with CF. In recent years, there has been a series of published studies exploring ncRNA expression and function in CF. The majority have focussed principally on miRNAs, with just a handful of reports to date on lncRNAs. The present study reviews what is currently known about ncRNA expression and function in CF, and discusses the possibility of applying this knowledge to the clinical management of CF in the near future.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  cystic fibrosis; long non-coding RNA; microRNA; non-coding RNA

Mesh:

Substances:

Year:  2018        PMID: 29743276     DOI: 10.1042/BST20170469

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

1.  New players in chronic lung disease identified at the European Respiratory Society International Congress in Paris 2018: from microRNAs to extracellular vesicles.

Authors:  Olivier Burgy; Elena Fernandez Fernandez; Sara Rolandsson Enes; Melanie Königshoff; Catherine M Greene; Sabine Bartel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells.

Authors:  Chiara De Santi; Elena Fernández Fernández; Rachel Gaul; Sebastian Vencken; Arlene Glasgow; Irene K Oglesby; Killian Hurley; Finn Hawkins; Nilay Mitash; Fangping Mu; Rana Raoof; David C Henshall; Meritxell B Cutrona; Jeremy C Simpson; Brian J Harvey; Barry Linnane; Paul McNally; Sally Ann Cryan; Ronan MacLoughlin; Agnieszka Swiatecka-Urban; Catherine M Greene
Journal:  Mol Ther       Date:  2020-02-06       Impact factor: 11.454

Review 3.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

4.  lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.

Authors:  Lifeng An; Jingwen Huang; Shihui Ge; Xin Zhang; Jing Wang
Journal:  Comput Math Methods Med       Date:  2022-06-06       Impact factor: 2.809

Review 5.  Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights.

Authors:  Justin E Ideozu; Xi Zhang; Susanna McColley; Hara Levy
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

Review 6.  Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis.

Authors:  Alison M D Hunt; Arlene M A Glasgow; Hilary Humphreys; Catherine M Greene
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

7.  Plasma microRNA levels in male and female children with cystic fibrosis.

Authors:  C Mooney; P J McKiernan; R Raoof; D C Henshall; B Linnane; P McNally; A M A Glasgow; C M Greene
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

8.  Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene.

Authors:  Chiara Papi; Jessica Gasparello; Matteo Zurlo; Alex Manicardi; Roberto Corradini; Giulio Cabrini; Roberto Gambari; Alessia Finotti
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

9.  Circular RNAs: Crucial regulators in the human body (Review).

Authors:  Yuanyong Wang; Tong Lu; Qian Wang; Jia Liu; Wenjie Jiao
Journal:  Oncol Rep       Date:  2018-09-25       Impact factor: 3.906

10.  Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis.

Authors:  Justin E Ideozu; Xi Zhang; Vittobai Rangaraj; Susanna McColley; Hara Levy
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.